Literature DB >> 24237650

Demonstrable professionalism: linking patient-centred care and revalidation.

G Phelps1, S Dalton.   

Abstract

The move by the Medical Board of Australia to commence a conversation with the medical profession about revalidation reflects that patient-centred care is at the heart of good medical practice. Patients judge their doctors' commitment to them based on whether their individual interactions with doctors meet their needs. We argue that ensuring that doctors are continuing to perform at a level that the community regards as acceptable is a demonstration of an individual doctor's professionalism and thus their commitment to patient-centred care. This impacts on the profession as a whole, which needs to commit to what we call 'demonstrable professionalism'--the ongoing and active demonstration of performance that the community regards as acceptable. This needs to be supported by organisations in which doctors work, reflecting the importance of organisational context to clinical practice. Revalidation processes thus need both to reflect the work of doctors and be meaningful to the community. The move to consider revalidation of doctors by regulatory authorities should not be seen by the profession as a threat, but more as an opportunity to demonstrate the profession's commitment to patient-centred care.
© 2013 The Authors; Internal Medicine Journal © 2013 Royal Australasian College of Physicians.

Entities:  

Keywords:  patient-centred care; performance; professionalism

Mesh:

Year:  2013        PMID: 24237650     DOI: 10.1111/imj.12280

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  2 in total

1.  The ESR Patient Advisory Group (ESR-PAG).

Authors: 
Journal:  Insights Imaging       Date:  2015-03-17

2.  Finding common ground: meta-synthesis of communication frameworks found in patient communication, supervision and simulation literature.

Authors:  Matthew Jon Links; Leonie Watterson; Peter Martin; Stephanie O'Regan; Elizabeth Molloy
Journal:  BMC Med Educ       Date:  2020-02-11       Impact factor: 2.463

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.